AN2 Therapeutics Executives Offload Shares Amidst Insider Selling Spree

AN2 Therapeutics, Inc. (ANTX) recently disclosed that Chief Development Officer Chanda Sanjay and other senior officers have engaged in share sales. On January 5, 2026, Sanjay sold 3,295 shares at $1 each, while Chief Financial Officer Day Lucy sold the same number of shares at the same price. On January 6, Sanjay sold 5,956 shares at $1.01 each, and Lucy sold 5,512 shares at the same price. Chief Operating Officer and Chief Legal Officer Eizen Joshua M sold 17,923 shares at $1 each on January 5, and 6,931 shares at $1.01 each on January 6. Chief Strategy Officer Prior Stephen David sold 2,858 shares at $1.01 each on January 6, and 3,604 shares at $1 each on January 5.